CAMBRIDGE, Mass., May 10, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today highlighted its recent clinical and business progress and announced its first quarter 2011 financial results. The company advanced key clinical programs in the first quarter, while also retaining its strong financial position and bolstering its senior management team.
